NCT07420751 2026-02-20
Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis
Massachusetts General Hospital
Phase NA Recruiting
Clinical Trials
26 trialsNCT07407582 2026-02-12
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
University of Arizona
Phase 1/2 Not yet recruiting
NCT06781749 2026-01-13
New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss
University of Southern California
Recruiting
NCT05789316 2026-01-12
Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)
Washington University School of Medicine
Phase NA Completed
NCT05582551 2025-12-22
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
Washington University School of Medicine
Phase NA Recruiting
NCT02310399 2025-10-30
Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves
NYU Langone Health
Phase NA Recruiting
NCT06036407 2025-05-30
HEAR
University of Bern
Phase NA Completed
NCT06894927 2025-05-30
HSA50+
University Hospital Hradec Kralove
Phase NA Enrolling by invitation
NCT06929468 2025-04-16
Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer
Paracelsus Medical University
Not yet recruiting
NCT05641441 2025-01-13
Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma
University Hospital, Geneva
Recruiting
NCT03745560 2024-11-25
Intraoperative EABR for Decision Making
Medical University of Vienna
Recruiting
NCT04609982 2024-08-21
SSNHL in Head & Neck Cancer Patients
Nova Scotia Health Authority
Phase NA Withdrawn
NCT03914378 2024-05-08
EARAD
University of Manchester
Recruiting
NCT06016335 2023-12-19
MRI-based Synthetic CT Images of the Head and Neck
Amsterdam UMC, location VUmc
Phase NA Completed
NCT04291209 2023-09-06
Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.
Sunnybrook Health Sciences Centre
Phase 1/2 Unknown
NCT05946577 2023-07-14
AURACCO
Assistance Publique - Hôpitaux de Paris
Not yet recruiting
NCT02094625 2023-04-18
NAC to Prevent Cisplatin-induced Hearing Loss
Children's Hospital Los Angeles
Phase 1 Completed
NCT05633719 2022-12-01
Multicenter, Prospective Observational Study for Early Diagnosis, and Development of Follow-up Protocol and Hearing Rehabilitation Program for Ototoxic Hearing Loss After Chemotherapy for Pediatric Solid Cancer
Seoul National University Hospital
Not yet recruiting
NCT04505696 2020-10-08
Providing Speech Therapy Awareness in Private Schools
Riphah International University
Phase NA Completed
NCT01864291 2020-06-02
ABI
Massachusetts Eye and Ear Infirmary
Phase NA Terminated
NCT01736267 2020-05-06
Auditory Brainstem Implant (ABI) in Adult Non-Neurofibromatosis Type 2 Subjects
Massachusetts Eye and Ear Infirmary
Phase NA Terminated
NCT02381782 2018-02-15
UHEAR
General Hospital Groeninge
Completed
NCT01969370 2017-05-03
NCGENES
University of North Carolina, Chapel Hill
Phase NA Completed
NCT00584155 2015-05-27
Protection From Cisplatin Ototoxicity by Lactated Ringers
University of Oklahoma
Phase 1 Withdrawn
NCT01225978 2014-01-24
RISGIM
Brigham and Women's Hospital
Unknown
NCT01102621 2010-04-13
Hearing Loss and Complaint in Patients With Head and Neck Cancer Treated With Radiotherapy
Hospital A.C. Camargo
Completed